October 9 may seem like just another day, but Tuesday marks a very significant day in the history of the US stock market. Today represents a day during which two major marketing turning points took place. On Oct. 9, 2002, the bottom of the bear market dissipated once the Internet bubble popped, and five years later, on the same day in 2007, the top of of the bull market arose, falsely leading us into the nation’s worst financial crisis since the Great Depression in 2009. Suffice to say, analysts, data scientists, and numerologist plan on staying near their closest emergency exit or available toilet.
Today marks the bull market’s ninth birthday, and earlier this year, a series of market thresholds were broken. CNN reports that in late January the Dow (DJI) “blew past the 20,000” threshold and then climbed above 21,000 just a month later.” Compared to nine years ago, the market is budding with life. In 2011, regular Americans had no interest in buying stocks, given that the Obama Administration was trying to wrestle the country free from the clutches of its debt.
“The mood today versus nine years ago (during the Great Recession) is quite dramatic. It’s polar-opposite. Back then, nobody wanted to buy stocks.”
– Joe Quinlan, Chief Investment Strategist at US Trust
Quinlan is spot on. Whether you are a Trump supporter or not, during this administration we have seen employment rates soar and job creation manifest across the nation. In response to the Dow’s breaking 20,000 in 2017, Trump couldn’t help but take a victory lap, especially given that this took place only one week after his inauguration. Trump exclaimed that America “just hit a record, and a number that’s never been hit before.” Since January 2017, the market has continued to entice Americans, who otherwise would refrain, to start investing.
CNN reports that individual investors, who have sat out for most of the bull market game, are starting to ask the coach to put them in, they’re ready to play. Global equity ETFs have seen $91.5 billion of inflows so far this year, according to Bank of America Merrill Lynch (BAC). It seems as though we are witnessing the return of the retail investor, as Americans grow more confident with the Bull market. For those of you reading that keep getting confused with talk of “Bull” and “Bear,” let’s step outside for some air real quick.
A “bull market” refers to a financial market in which prices are increasing or projected to increase, whereases when a market is bearish, it does the exact opposite. The use of these metaphors to describe the stock market is derived from the way each animal attacks its opponents. When a bull attacks, it thrusts its horns in the air, while Yogi the Bear swipes his paws down. So bull market means “up,” and bear market means, “down.”
Back to our regularly scheduled program.
The Bull Market we are currently trading in is the 2nd in history, following a bull trend that spanned from 1949 to 1956. The current trend arose from the rubble of the Great Recession nearly two years ago in April 2016. Some are concerned that entering the market this late in the game is too late, and the tides could shift at any moment. Sam Stovall, chief investment strategist at CFRA Research wrote in a report that “bull markets don’t die of old age, they die of fright.” Stovall’s report suggests that our fear of investing and avoiding of the stock market because it may become bearish will be our own demise. This poses a schroedinger’s cat of sorts. Investing in the stock market is inherently risk-oriented, so an investor must be prepared for the market to shift on a moment’s notice. At the same time, fear of the market collapsing, according to Stovall, will cause the market to, in fact, do exactly what we fear most.
Alternative to this speculation, stocks have grown increasingly more expensive in recent months, so a fear that investors will start to drastically sell isn’t too far off base. According to CNN, as the Trump administration continues to promise tax cuts, tariffs on Chinese goods, and other policy changes, “valuations have climbed uncomfortably high.” Our friend, Stovall, writes that investors should now be on the lookout for a FOMO (fear of missing out) mindset that could signal overconfidence and sound the final lap of this bull market.”
While analysts hope to predict the next market top or bottom, it is highly unlikely that when the day comes for the market trend to shift, we will even recognize it. As the saying goes, “they don’t ring a bell at market tops.”
Biotechnology Could Cure It All
Nearly two-thousand years ago, give or take several minutes, Hippocrates taught that human existence was centered around the four elements — earth, water, fire, and air — which in the human body was represented by the four basic humors: blood, phlegm, black bile, yellow bile. Hippocrates explained that each humor was located in a specific organ of the human body and each related to its own personality type — sanguine, phlegmatic, melancholic, and choleric.
‘Therefore, if someone was sick, Hippocrates taught that this indicated an imbalance in one of the four
Suffice to say that the medical field has moved forward since 460 BC, and recently, these advancements have occurred in the biotechnology industry. Though biotech is a relatively new field, it possesses great potential for the future of medicine. One of the more recent breakthroughs in biotech stems from something called pharmacogenomics, or the study of how genetics affect a person’s response to drugs. This new field combines the science of developing drug treatments and research conducted on human genetics and their functions.
According to the U.S. National Library of Medicine, most drugs currently available on the market are branded as “one size fits all,”meaning that this specific treatment was created to cure a certain ailment for anyone who takes it. However, as scientists in the pharmacogenomics field are discovering, not everyone reacts the same to certain drugs.
For example, if two individuals are having an allergic reaction and both ingest an anti-histamine, it’s possible that it will help one person feel better, while causing adverse side-effects to the other person. By studying a person’s genetic coding, medical experts are better able to predict how a medication will effect a particular person.
Ironically enough, as new technologies and inventive approaches to curing diseases come to light, medical researchers are discovering new diseases that seek to test all the progress we’ve made thus far. The practices of medicine have taken massive strides over the past few generations through the pioneering of biotechnology research and other incredible advancements, but regardless of these steps forward, it is up to companies in the healthcare industry to responsibly tend to the needs of their patients.
Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) / (6PH.F) is a Canadian publicly traded company strategically poised to take advantage of lucrative business opportunities in the global healthcare industry. The Company is working to develop innovative healthcare approaches that combine human skill-based expertise with emerging technologies. What sets the Company apart from others in the field is that Premier is focused on developing their healthcare platform with a patient centric focus, looking to restore power back to the patients. For far too long, patients have been at the mercy of pharmaceutical companies who, by virtue of their capital, have maintained a chokehold on the price of drugs that patients need to stay healthy.
In addition to rising treatments costs, as the global population increases, there are less primary physicians available for consumers looking to be cured. Through the use of Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) / (6PH.F) HealthVue app, patient can see their physician, access their charts & lab results, chat securely with clinical staff, reorder prescriptions and share remote health monitoring data with their doctor – all at their fingertips. The HealthVue app utilizes a virtual care platform designed to be easy to use and to improve a patient’s access to primary care.
In addition these advanced healthcare solutions, the Company shared, in their most recent corporate update, that they plan on utilizing artificial intelligence to assist in virtually triaging the needs of their patients. Using their Healthvue app, the patient will answer a series of questions which will be relayed to the physician, along with a differential on possible diagnoses. This information will be pre-populated to the physicians charting system and will provide key patient information prior to the scheduled virtual visit, saving them a considerable amount of time and allowing more time for patient interaction.
Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 ( CASH) for & were paid “500,000” shares of restricted common shares (as of 1/2/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the “500,000” shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Please click here for full disclaimer.
Stock Price Newsletter – February 21, 2019
Mueller Investigation Is Almost Ready
A half-witted, know-nothing playwright by the name of William Shakespeare once wrote that “these violent delights have violent ends.” The line, taken from Shakespeare’s Romeo and Juliet, also featured in Westworld, depicts a scene in which Friar Laurence cautions Romeo into falling for Juliet because his love may catalyze his own violent end. I attribute the words of Shakespeare to the current predicament facing President Donald Trump and his administration. In the two or so years since Trump took office, special counsel Robert Mueller has worked without end to investigate whether the Trump administration colluded in any way, shape, or form, with Russia during the 2016 presidential election.
After countless subpoenas and inducements of former Trump associates and administration members, sources indicate that Mueller’s long nights away from the family could soon be over. Towards that end of January, Roger Stone, a former associate of Donald Trump before he became president, was indicted on charges of seeking stolen emails from WikiLeaks that could damage Trump’s opponents during the 2016 presidential election season.
Per the official language of the indictment:
“…After the 2016 U.S. presidential election, the U.S. House of Representatives Permanent Select Committee on Intelligence, the U.S. Senate Select Committee on Intelligence, and the Federal Bureau of Investigation opened or announced their respective investigations into Russian interference in the 20126 U.S. presidential election…Stone took steps to obstruct these investigations….He made false statements to the HPSCI about his interactions regarding WikiLeaks, and falsely denied possessing records that contained evidence…”
-Robert Stone indictment
The indictment went on to explain that Stone attempted to persuade a witness to provide false testimony and withheld pertinent information from federal investigators. According to several sources, Stone was arrested by the FBI Friday morning while drinking his morning coffee at his home in Florida. Stone’s attorney immediately attempted to defuse any public sentiment stirring up connecting Stone to special counsel Mueller’s investigation, suggesting that Stone’s indictment “focuses on allegedly false statements…made to Congress,” and has nothing to do with Russian collusion.
According to CNN, Attorney General Bill Barr is limbering up in preparation to announce as early as next week the completion of Robert Mueller’s investigation, “with plans for Barr to submit to Congress soon after a summary” of the confidential report is prepared. Interestingly enough, though the details of the report concern both the American people and its presiding government, under special counsel regulations, Mueller must submit his “report” to the attorney general and the law doesn’t require this document to be shared with anyone.
Barr is under no formal obligation to publicly share the report, but I can already assume that members of the Democratic leadership will be banging on his office door until he throws them a bone.
The question on everyone’s mind is, what Mueller discovered in his lengthy investigation. Mueller was appointed to the case on May 17, 2017, and in years following this date, Mueller has had his hands full. Early last week, Mueller’s office filed its sentencing memorandum against Paul Manafort, Trump’s former campaign manager, who will be sentenced next month in federal district court in the District of Columbia.
“For a decade, Manafort repeatedly violated the law. Considering only the crimes charged in this district, they make plain that Manafort chose to engage in a sophisticated scheme to hide millions of dollars from United States authorities. The sentence in this case must take into account the gravity of this conduct, and serve to both specifically deter Manafort and those who would commit a similar series of crimes.”
–sentencing memo from Robert Mueller
As for the findings of Mueller’s investigation, we will have to wait and see how Attorney General Barr chooses to go about sharing the report, if he ends up sharing the information at all. The information could disturb the Trump presidency and possibly give Democrats grounds for introducing articles of impeachment.
Search Stock Price (StockPrice.com)
Editorials2 months ago
Multi-Trillion Dollar Industry Providing Massive Opportunity in 2019 & Beyond
Featured4 months ago
Opportunity Ahead → Telemedicine the Future of Primary Care
Sponsored Content4 months ago
Special Delivery! On-Demand Tech Companies Hit Billion-Dollar Valuations; Here’s How Investors Can Capitalize In The Market
Featured4 months ago
Premier Health Group Inc. (OTC: PHGRF) (CSE: PHGI) Announces Plans to Enter Canadian Pharmacy & Drug Store Market
Newsletter4 months ago
Stock Price: Newsletter Tuesday 11/5/2018
Editorials5 months ago
2 NAFTA 2 Furious!
Editorials5 months ago
Brews with Brett; Why the Supreme Court Nominee’s Favorite Drink May Be His Downfall
Editorials5 months ago
China Offers New “Spy-cy” Chip Flavor, Apple & Amazon Can’t Stand Heat